동아에스티

170900KOSPIView the 제약 sectorTheme Bio & healthcare

36,100KRWMarket close of 10/20 (Tue)

Up +0.28%+100KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)35,450KRWDown -1.80%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
36,000
High
36,800
Low
35,600
Day range
Day range low 35,600 high 36,800, open 36,000, close 36,100, previous close 36,000
Volume
1×10K shares
328.99 million KRW 1.11× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 32,000 to 57,800 won, 16% up from the low

16% of the way up from the lowest close in 1 year (252 sessions) · -37.5% from the high

Usual range

Nothing unusual in the 4 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
  • Daily moveusual range+0.28%+0.28%, 0.3× the usual (20-session average ±0.98%)
    That day +0.28% · usual ±0.98% · large-move threshold ±3.0%

The other 3 are within the usual range

  • Trading value1.1×usual range
  • EarningsOperating income, 8 quartersOperating income, 8 quarters
  • Data date10/20 (Tue)Market close
See the full check report

Quarterly results · Q1 2026

  • Revenue203.6B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +11.8%
    vs. prior quarter
    -6.1%
  • Operating income7.8B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Turned profitable
    vs. prior quarter
    Turned profitable
  • Operating margin3.8%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +6.5 pp
    vs. prior quarter
    +5.1 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15
2021Q1 879.53 million KRW2026Q1 7.8B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.